Moderna Stock Plummets as 2025 Sales Forecast Cut by $1 Billion Amid Vaccine Challenges
Moderna's shares dropped 17% following a $1 billion reduction in its 2025 revenue forecast, driven by declining Covid vaccine market share and lower vaccination rates. The biotech company plans aggressive cost-cutting measures while maintaining optimism about its future product pipeline.
Walgreens Stock Rises Despite $5.9B Loss as Strategic Restructuring Takes Shape
Walgreens Boots Alliance saw its shares climb despite reporting a massive quarterly loss driven by VillageMD write-downs. Investors were encouraged by strong pharmacy sales growth and aggressive restructuring plans under new CEO Tim Wentworth.
RxSight Shares Rally After Launch of Advanced Cataract Surgery Lens Technology
RxSight's stock surged over 7% following the release of its enhanced Light Adjustable Lens+ for cataract surgery patients. The medical technology company showcased strong financial performance with 78% Q4 revenue growth and projected continued expansion through 2024.
Johnson & Johnson Stock Dips Following Mixed Q1 Results and Revised 2024 Outlook
Healthcare giant Johnson & Johnson experienced a 2% stock decline after reporting mixed Q1 2024 results, with revenue beating expectations but earnings falling short. The company narrowed its full-year guidance amid market uncertainties while maintaining its status as a dividend aristocrat.